Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Tipo de estudo
Intervalo de ano
1.
SJO-Saudi Journal of Ophthalmology. 2016; 30 (2): 140-143
em Inglês | IMEMR | ID: emr-180400

RESUMO

Congenital optic nerve abnormalities may rarely cause choroidal neovascularization [CNV]. This case report summarizes the clinical and therapeutic outcomes of a 7-year-old boy with unilateral CNV secondary to morning glory syndrome associated with acute visual acuity loss. The patient was successfully treated with a single intravitreal ranibizumab injection. One month after the injection the visual acuity increased and optic coherence tomography [OCT] showed a decrease in the intraretinal fluid around the CNV. The patient was then called for monthly follow-up visits. No further treatment was needed for the next 12 months after the first treatment. There was no complication related to the injection

2.
MEAJO-Middle East African Journal of Ophthalmology. 2014; 21 (2): 186-188
em Inglês | IMEMR | ID: emr-142140

RESUMO

We performed various ophthalmic investigations in order to confirm the diagnosis and document the various features of posterior microphthalmos in a 21-year-old male. Ophthalmic examination revealed low vision with high hyperopia, papillomacular folds, midperipheral pigmentary changes and crowded optic discs. The optic discs were small and crowded with increased nerve fiber layer thickness. Fundus fluorescein angiography showed reduced diameter of a capillary free zone. Anterior segment [AS] optical coherence tomography demonstrated near normal anterior chamber depths, but markedly diminished anterior chamber angles. In spite of the increased corneal thickness and steep corneas, lens thickness and endothelial cell counts were normal. Sclerochoroidal thickening and foreshortening of the globes were detected with B-scan ultrasonography. Electroretinographic findings and visual field tests were similar to those in pigmentary retinopathy. Posterior microphthalmos is a complex eye disorder, which affects predominantly the posterior segment but also involves the AS of the eye.


Assuntos
Humanos , Masculino , Tomografia de Coerência Óptica , Segmento Anterior do Olho , Angiofluoresceinografia , Fundo de Olho , Imagem Óptica
3.
MEAJO-Middle East African Journal of Ophthalmology. 2013; 20 (4): 360-362
em Inglês | IMEMR | ID: emr-148528

RESUMO

The clinical and imaging findings and therapeutic outcomes of intravitreal bevacizumab injection in a patient with macular telangiectasia type 2 are described. The patient first presented with the non-proliferative stage of the disease for 4 months, then the disease transformed to the proliferative stage. In the proliferative period, the patient was treated with intravitreal bevacizumab injections as-clinically warranted. Over a follow up period lasting 26 months, the patient received 6 intravitreal bevacizumab injections, the visual acuity improved from 20/100 to 20/40, the central retinal thickness decreased from 318 microns to 198 microns. This case implies that the patients with non-proliferative macular telangiectasia type 2 should be followed carefully for proliferative transformation, and intravitreal bevacizumab treatment seems to be effective for proliferative macular telangiectasia type 2


Assuntos
Humanos , Feminino , Telangiectasia/tratamento farmacológico , Doenças Retinianas/terapia , Anticorpos Monoclonais Humanizados/administração & dosagem , Anticorpos Monoclonais Humanizados , Injeções Intravítreas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA